Sign up for our Weekly Checkup Newsletter
Segment reports · Diagnostics / Life Sciences

Diagnostics / Life Sciences

M&A valuation multiples for healthcare businesses (revenue and EBITDA multiples)

What you get
  • 242 transactions since 2010, 106 with EBITDA multiples
  • Data updated Oct 12, 2026
  • One Excel workbook, delivered as a download link on checkout and by email
  • Single-use license for your firm's project
  • Price $1,500, one-time

Need every segment, refreshed weekly? Enterprise subscriptions cover the whole database.

Diagnostics / Life Sciences segment report

Secure checkout by Stripe. The download link arrives on the next page and by email.

Diagnostics / Life Sciences M&A Valuation Segment Report

Comparable Transactions / Precedent Deals

Excel spreadsheet with Scope Research's diagnostics and life sciences M&A valuation data and benchmarking tools. Transactions are segmented by type, which include a variety of laboratories, diagnostic tools, and life sciences equipment providers.

  • 242 transactions with revenue or EBITDA multiples (since 2010)
  • 106 of these deals have reported EBITDA multiples
  • Last updated 10/12/2026

Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented.

All transactions included in the Scope Research healthcare M&A valuation database are meticulously researched and sourced. Our internal records include an audit trail of links to the majority of our sources.